Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

(2009) Sharon Nofech-Mozes et al.   BREAST CANCER RESEARCH AND TREATMENT

Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years

(2009) J. M. Dolle et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

(2009) F. Andre et al.   CLINICAL CANCER RESEARCH

High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?

(2009) Yago Nieto et al.   CURRENT OPINION IN ONCOLOGY

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Basal Phenotype in Breast Carcinoma Occurring in Women Aged 35 or Younger

(2009) Rita Bori et al.   PATHOLOGY & ONCOLOGY RESEARCH

Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings

(2009) Takayoshi Uematsu et al.   RADIOLOGY

Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics

(2009) Junichi Kurebayashi   Breast Cancer

Breast Carcinoma with Basal Phenotype: Mammographic Findings

(2008) Angela A. Luck et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer

(2008) S. L. Hines et al.   ANNALS OF ONCOLOGY

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial

(2008) O. Gluz et al.   ANNALS OF ONCOLOGY

Targeting Src in breast cancer

(2008) R. S. Finn   ANNALS OF ONCOLOGY

Platinum-based chemotherapy in triple-negative breast cancer

(2008) B. Sirohi et al.   ANNALS OF ONCOLOGY

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

(2008) Tatsuya Toyama et al.   BMC CANCER

Pattern of metastatic spread in triple-negative breast cancer

(2008) Rebecca Dent et al.   BREAST CANCER RESEARCH AND TREATMENT

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

(2008) Monzur Rahman et al.   BREAST CANCER RESEARCH AND TREATMENT

Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity

(2008) Giuseppe Viale et al.   BREAST CANCER RESEARCH AND TREATMENT

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype

(2008) S E Elsheikh et al.   BRITISH JOURNAL OF CANCER

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer

(2008) Nancy U. Lin et al.   CANCER

High prevalence of triple-negative tumors in an urban cancer center

(2008) Mary Jo B. Lund et al.   CANCER

Therapeutic Strategies for Triple-Negative Breast Cancer

(2008) Antoinette R. Tan et al.   CANCER JOURNAL

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH

Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer

(2008) Simon J. Crabb et al.   Clinical Breast Cancer

Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node-Negative Cohort

(2008) A. M. Mulligan et al.   CLINICAL CANCER RESEARCH

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

MYC in breast tumor progression

(2008) Yinghua Chen et al.   Expert Review of Anticancer Therapy

How basal are triple-negative breast cancers?

(2008) François Bertucci et al.   INTERNATIONAL JOURNAL OF CANCER

Basal-like subtype and BRCA1 dysfunction in breast cancers

(2008) Yasuo Miyoshi et al.   International Journal of Clinical Oncology

Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer

(2008) Deann P. Atchley et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

(2008) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-negative/basal-like breast cancer: review

(2008) Emad A. Rakha et al.   PATHOLOGY

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

(2008) S. Rottenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Is triple negative a prognostic factor in breast cancer?

(2008) Reiki Nishimura et al.   Breast Cancer

Evaluation of Morphologic Features to Identify “Basal-like Phenotype” on Core Needle Biopsies of Breast

(2008) Mamatha Chivukula et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters

(2007) Sandip Basu et al.   CANCER

The Influence of Basal Phenotype on the Metastatic Pattern of Breast Cancer

(2007) A.A. Luck et al.   CLINICAL ONCOLOGY